|
Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.A review of the device history record has been initiated.If any deviations or non-conformances are found, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
|
|
Healthcare professional reported ¿inflammatory nodule, some visible¿ on their lower right jaw, above/upper lips and marionette region, 6 months after injection with one syringe of juvéderm volbella® xc.Treatment is noted as ciprofloxacin, doxycycline, prednisone, and hylenex.Two weeks after filler patient had a heart attack.Patient had shingles, a sinus and ear infection four months after injection, lasting for 3 months; these were determined to not be device related.Events are ongoing at this time.Patient was concomitantly injected with 2 syringes of juvéderm vollure¿ xc.This is the same event and the same patient reported under mdr id # 3005113652-2019-00535 (allergan (b)(4)).This mdr is being submitted for juvéderm volbella® xc.
|